Literature DB >> 24673886

3-Hydroxybutyrate dehydrogenase-2 and ferritin-H synergistically regulate intracellular iron.

Zhuoming Liu1, Kiran K Velpula, Lax Devireddy.   

Abstract

Siderophores are best known as small iron-binding molecules that facilitate iron uptake in bacteria and fungi. In our previous study, we demonstrated that eukaryotes also produce siderophore-like molecules via a remarkably conserved biosynthetic pathway. A member of the short-chain dehydrogenase family of reductases, 3-hydroxybutyrate dehydrogenase-2, catalyzes a rate-limiting step in the biogenesis of the mammalian siderophore. Physiologically, depletion of the mammalian siderophore by inhibiting expression of the 3-hydroxybutyrate dehydrogenase-2 gene (Bdh2) results in abnormal accumulation of intracellular iron, increased oxidative stress, and mitochondrial iron deficiency. Thus, the mammalian siderophore is an important regulator of cellular iron homeostasis. The cellular iron storage protein ferritin also regulates iron metabolism and protects cells from oxidative stress. Depletion of ferritin results in intracellular iron accumulation, predisposes to oxidative stress, and confers a growth advantage to cells. We therefore hypothesize that the siderophore and ferritin coregulate cellular iron metabolism/homeostasis in eukaryotes. We tested this prediction by depleting both the siderophore and ferritin. This resulted in a marked accumulation of cellular iron, and caused increased sensitivity to oxidants. Interestingly, cells lacking both the siderophore and ferritin proliferated at a higher rate than cells lacking either of these components alone. Taken together, our findings suggest that the siderophore and ferritin synergistically regulate cellular iron levels.
© 2014 FEBS.

Entities:  

Keywords:  3-hydroxybutyrate dehydrogenase-2; apoptosis; cellular iron metabolism; ferritin-H; reactive oxygen species

Mesh:

Substances:

Year:  2014        PMID: 24673886     DOI: 10.1111/febs.12794

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  7 in total

1.  Role of lipocalin-2 in brain injury after intracerebral hemorrhage.

Authors:  Wei Ni; Mingzhe Zheng; Guohua Xi; Richard F Keep; Ya Hua
Journal:  J Cereb Blood Flow Metab       Date:  2015-04-08       Impact factor: 6.200

Review 2.  Expanding Roles of Noncoding RNAs in the Pathogenesis of Systemic Lupus Erythematosus.

Authors:  Yiwei Shen; Bo Qu; Nan Shen
Journal:  Curr Rheumatol Rep       Date:  2022-03-03       Impact factor: 4.592

3.  Protective Effects of Dexrazoxane against Doxorubicin-Induced Cardiotoxicity: A Metabolomic Study.

Authors:  Yang QuanJun; Yang GenJin; Wan LiLi; Han YongLong; Huo Yan; Li Jie; Huang JinLu; Lu Jin; Gan Run; Guo Cheng
Journal:  PLoS One       Date:  2017-01-10       Impact factor: 3.240

4.  BDH2 triggers ROS-induced cell death and autophagy by promoting Nrf2 ubiquitination in gastric cancer.

Authors:  Jia-Zhou Liu; Yi-Lin Hu; Ying Feng; Yun Jiang; Yi-Bing Guo; Yi-Fei Liu; Xi Chen; Jun-Ling Yang; Yu-Yan Chen; Qin-Sheng Mao; Wan-Jiang Xue
Journal:  J Exp Clin Cancer Res       Date:  2020-06-30

5.  Inactivation of 3-hydroxybutyrate dehydrogenase type 2 promotes proliferation and metastasis of nasopharyngeal carcinoma by iron retention.

Authors:  Bo Li; Zhipeng Liao; Yingxi Mo; Weilin Zhao; Xiaohui Zhou; Xiling Xiao; Wanmeng Cui; Guofei Feng; Suhua Zhong; Yushan Liang; Chunping Du; Guangwu Huang; Ping Li; Xue Xiao; Xiaoying Zhou; Rensheng Wang; Zhe Zhang
Journal:  Br J Cancer       Date:  2019-12-10       Impact factor: 7.640

6.  Inflammation and ER stress downregulate BDH2 expression and dysregulate intracellular iron in macrophages.

Authors:  Susu M Zughaier; Brandon B Stauffer; Nael A McCarty
Journal:  J Immunol Res       Date:  2014-12-01       Impact factor: 4.818

Review 7.  Iron Handling in Tumor-Associated Macrophages-Is There a New Role for Lipocalin-2?

Authors:  Michaela Jung; Andreas Weigert; Christina Mertens; Claudia Rehwald; Bernhard Brüne
Journal:  Front Immunol       Date:  2017-09-20       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.